Objective
Seeks long-term capital appreciation through investment in securities markets outside the United States.
Overview
A high-conviction international equity fund that seeks to exploit growth gaps through fundamental research.
The portfolio managers are supported by the full resources of Schroders.
Simon Webber, CFA
Equity Portfolio Manager
Performance
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
SI = Since Inception.
Fund Inception: 12/19/1985
Performance prior to 10/24/16 for Class I-shares reflects the performance, fees, and expenses of the Investor Class of the predecessor fund Schroder International Alpha Fund. If Class I fees and expenses were reflected, performance would have differed. SI performance is calculated from 12/19/85.
Characteristics
# of Holdings | 48 |
Turnover- (12/31/2022) | 35% |
Active Share | 84% |
FUND | MSCI ACWI ex USA Index | |
---|---|---|
Price/Earnings | 15.6x | 12.4x |
Price/Book | 2.6x | 1.7x |
Asset Weighted Market Cap (billions) | $119.2 | $82.9 |
Median Market Cap (billions) | $71.5 | $8.6 |
Return on Equity | 15.8% | 14.3% |
Continental Europe | 42 |
United Kingdom | 19 |
Emerging Markets | 14 |
Japan | 12 |
North America | 6 |
Canada | 4 |
Pacific ex Japan | 3 |
Taiwan Semiconductor Manufacturing Co., Ltd. | 3.36 |
AIA Group Ltd. | 2.93 |
Samsung Electronics Co., Ltd. | 2.91 |
Shell plc | 2.90 |
Nestle S.A. | 2.89 |
SAP SE | 2.78 |
Siemens AG | 2.68 |
Schneider Electric SE | 2.57 |
Mitsubishi UFJ Financial Group, Inc. | 2.56 |
AstraZeneca plc | 2.49 |
Total Portfolio % | 28.07 |
Less than $2 billion | 0 | |
$2 billion - $5 billion | 0 | |
$5 billion - $10 billion | 0 | |
Greater than $10 billion | 100 | |
Not Classified | 0 |
Alpha (5 Year)
|
4.22 |
Down Capture (5 Year)
|
102.30 |
Information Ratio (5 Year)
|
0.99 |
Sharpe Ratio (5 Year)
|
0.32 |
Up Capture (5 Year)
|
119.52 |
FUND |
BENCHMARK | UNDERWEIGHT / OVERWEIGHT | |||||
---|---|---|---|---|---|---|---|
12/31/22 | 2/28/23 | 2/28/23 | -7 0 7 | ||||
Industrials | 18 | 19 | 13 | ||||
Information Technology | 15 | 16 | 11 | ||||
Consumer Staples | 11 | 11 | 9 | ||||
Health Care | 11 | 11 | 9 | ||||
Consumer Discretionary | 14 | 13 | 12 | ||||
Utilities | 3 | 3 | 3 | ||||
Communication Services | 4 | 4 | 6 | ||||
Real Estate | 0 | 0 | 2 | ||||
Financials | 17 | 18 | 21 | ||||
Energy | 5 | 3 | 6 | ||||
Materials | 1 | 1 | 8 |
Insights
Fund Literature